Taiwan · Delayed Price · Currency is TWD Ttbio Statistics
Total Valuation
Ttbio has a market cap or net worth of TWD 430.50 million. The enterprise value is 585.98 million.
| Market Cap | 430.50M |
| Enterprise Value | 585.98M |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | Jul 28, 2025 |
Share Statistics
Ttbio has 24.05 million shares outstanding. The number of shares has decreased by -0.05% in one year.
| Current Share Class | 24.05M |
| Shares Outstanding | 24.05M |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 0.22% |
| Owned by Institutions (%) | 1.26% |
| Float | 5.20M |
Valuation Ratios
The trailing PE ratio is 166.21.
| PE Ratio | 166.21 |
| Forward PE | n/a |
| PS Ratio | 1.38 |
| PB Ratio | 1.46 |
| P/TBV Ratio | 1.71 |
| P/FCF Ratio | 23.31 |
| P/OCF Ratio | 16.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.18, with an EV/FCF ratio of 31.73.
| EV / Earnings | 226.25 |
| EV / Sales | 1.88 |
| EV / EBITDA | 17.18 |
| EV / EBIT | n/a |
| EV / FCF | 31.73 |
Financial Position
The company has a current ratio of 1.83, with a Debt / Equity ratio of 0.81.
| Current Ratio | 1.83 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 6.98 |
| Debt / FCF | 12.89 |
| Interest Coverage | -0.46 |
Financial Efficiency
Return on equity (ROE) is 0.87% and return on invested capital (ROIC) is -0.29%.
| Return on Equity (ROE) | 0.87% |
| Return on Assets (ROA) | -0.26% |
| Return on Invested Capital (ROIC) | -0.29% |
| Return on Capital Employed (ROCE) | -0.56% |
| Revenue Per Employee | 2.65M |
| Profits Per Employee | 21,949 |
| Employee Count | 118 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.20 |
Taxes
In the past 12 months, Ttbio has paid 808,000 in taxes.
| Income Tax | 808,000 |
| Effective Tax Rate | 23.78% |
Stock Price Statistics
The stock price has decreased by -11.60% in the last 52 weeks. The beta is 0.25, so Ttbio's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -11.60% |
| 50-Day Moving Average | 17.75 |
| 200-Day Moving Average | 19.25 |
| Relative Strength Index (RSI) | 46.18 |
| Average Volume (20 Days) | 5,268 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ttbio had revenue of TWD 312.12 million and earned 2.59 million in profits. Earnings per share was 0.11.
| Revenue | 312.12M |
| Gross Profit | 72.77M |
| Operating Income | -2.29M |
| Pretax Income | 3.40M |
| Net Income | 2.59M |
| EBITDA | 26.36M |
| EBIT | -2.29M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
The company has 82.60 million in cash and 238.08 million in debt, giving a net cash position of -155.48 million or -6.46 per share.
| Cash & Cash Equivalents | 82.60M |
| Total Debt | 238.08M |
| Net Cash | -155.48M |
| Net Cash Per Share | -6.46 |
| Equity (Book Value) | 295.11M |
| Book Value Per Share | 12.27 |
| Working Capital | 168.62M |
Cash Flow
In the last 12 months, operating cash flow was 25.35 million and capital expenditures -6.88 million, giving a free cash flow of 18.47 million.
| Operating Cash Flow | 25.35M |
| Capital Expenditures | -6.88M |
| Free Cash Flow | 18.47M |
| FCF Per Share | 0.77 |
Margins
Gross margin is 23.32%, with operating and profit margins of -0.73% and 0.83%.
| Gross Margin | 23.32% |
| Operating Margin | -0.73% |
| Pretax Margin | 1.09% |
| Profit Margin | 0.83% |
| EBITDA Margin | 8.44% |
| EBIT Margin | -0.73% |
| FCF Margin | 5.92% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 1.41%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 1.41% |
| Dividend Growth (YoY) | -16.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 278.57% |
| Buyback Yield | 0.05% |
| Shareholder Yield | 1.44% |
| Earnings Yield | 0.60% |
| FCF Yield | 4.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ttbio has an Altman Z-Score of 1.84 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.84 |
| Piotroski F-Score | 4 |